Clinical Trials Directory

Trials / Completed

CompletedNCT07137988

Effect of Acute Grape Seed Extract Supplementation on the Heart Rate Recovery in Young Individuals

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
California Baptist University · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

This study hypothesized that sustained sympathoexcitation via MMA slows down PHRR and that GSE supplementation is effective at improving PHRR in young individuals. 12 Participants were randomly assigned, via a double-blind, cross-over design, to either receive GSE (300mg, 2 capsules) or PL (300mg, 2 capsules), with a washout period of at least 72 hrs. between trials. A submaximal exercise test was performed using a cycle ergometer combined with isometric handgrip exercise using a handgrip dynamometer, and blood flow occlusion by placing a cuff over the brachial artery of the dominant arm. Post heart rate recovery (PHRR) was measured at 5 sec. intervals throughout the experiment. The PHRR was evaluated between GSE and PL at every min. for 300 sec.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT600 mg grape seed extractEach participant took either GSE (300 mg, 2 capsules) or a placebo (300 mg, 2 capsules filled with starch) 2 hours before their scheduled lab visit. The supplements were made to look identical to prevent any bias from the participants or the testers. There was a washout period of at least 72 hours, but no more than a week, between each trial.
DIETARY_SUPPLEMENT600 mg StarchEach participant took either GSE (300 mg, 2 capsules) or a placebo (300 mg, 2 capsules filled with starch) 2 hours before their scheduled lab visit. The supplements were made to look identical to prevent any bias from the participants or the testers. There was a washout period of at least 72 hours, but no more than a week, between each trial.

Timeline

Start date
2024-10-03
Primary completion
2024-12-03
Completion
2024-12-31
First posted
2025-08-22
Last updated
2025-08-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07137988. Inclusion in this directory is not an endorsement.